Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials • Semiconductors, Circuits & Optics
9 pending office actions • 4 art units • 9 examiners • 0 of 9 (0%) have an AI response strategy ready • 15 patents granted in the last 365 days
Sun Yat-sen University exhibits an active prosecution profile in the Biotechnology & Pharmaceuticals technology area, with 9 pending office actions. These matters are spread across 4 distinct art units, reflecting a research focus that spans multiple technical divisions. The university is currently working with 9 distinct examiners, meaning every pending action is being reviewed by a different individual. This level of examiner diversity necessitates an adaptable prosecution approach.
GHORISHI, SEYED BEHROOZ is listed as the busiest examiner, though he is only responsible for 1 pending office action. This indicates an even distribution of the 9 pending office actions across the 9 distinct examiners. Managing such a portfolio requires navigating the specific requirements of 4 different art units and the individual tendencies of these separate examiners. The high number of 9 pending office actions suggests an ongoing investment in securing intellectual property rights within the Biotechnology & Pharmaceuticals technology area. The university must coordinate its legal strategy across a wide array of USPTO personnel.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 5 (56%) |
| §103 only | 1 (11%) |
| Multi-statute (no §101) | 3 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GHORISHI, SEYED BEHROOZ | 1 | 68.8% | +44.0% |
| BERKE-SCHLESSEL, DAVID W | 1 | 66.7% | +31.8% |
| CREWS, JARET JAMES | 1 | 44.7% | +70.3% |
| CUTLIFF, YATE KAI RENE | 1 | 79.8% | +24.3% |
| LEE, CHIHYI NMN | 1 | 33.7% | +60.8% |
| COCCHI, MICHAEL EDWARD | 1 | 40.9% | +47.7% |
| NEGIN, RUSSELL SCOTT | 1 | 55.9% | +34.2% |
| PUTTLITZ, KARL J | 1 | 69.1% | +18.6% |
| HARVEY, MINSUN OH | 1 | 72.5% | -1.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18318728 | DFB LASER MANUFACTURING METHOD BASED ON DIELECTRIC LATERALLY COUPLED GRATING WITH DETERMINISTIC GRATING COUPLING COEFFICIENT | HARVEY, MINSUN OH | 30d |
| 18999089 | METHOD, APPARATUS, DEVICE, AND MEDIUM FOR SIMULATINGPOLYURETHANE PERMEATION GROUTING DIFFUSION | GHORISHI, SEYED BEHROOZ | — |
| 18959230 | BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS, MICROBIAL AGENT AND USE THEREOF | BERKE-SCHLESSEL, DAVID W | — |
| 17619922 | METHOD FOR PREPARING PT-BASED ALLOY / MOFS CATALYST WITH HIGH HYDROGENATION SELECTIVITY AND APPLICATION THEREOF | CUTLIFF, YATE KAI RENE | — |
| 18512177 | CHIRAL OR RACEMIC PYRIMIDINE-FUSED DIAZEPINONE DERIVATIVES, PREPARATION METHOD, AND APPLICATION THEREOF | LEE, CHIHYI NMN | — |
| 18280945 | METHOD AND SYSTEM FOR ANALYZING PRECIPITATION NORMALIZATION BY GRADIENT-BASED PARAMETER OPTIMIZATION | COCCHI, MICHAEL EDWARD | — |
| 18232363 | METHOD AND DEVICE FOR CONSTRUCTING AUTISM SPECTRUM DISORDER (ASD) RISK PREDICTION MODEL | NEGIN, RUSSELL SCOTT | — |
| 18325792 | BIOMARKER FOR DIAGNOSIS, TREATMENT, AND PROGNOSIS FOR HEPATOCELLULAR CARCINOMA BONE METASTASIS AND APPLICATION THEREOF | PUTTLITZ, KARL J | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18999089 | METHOD, APPARATUS, DEVICE, AND MEDIUM FOR SIMULATINGPOLYURETHANE PERMEATION GROUTING DIFFUSION | GHORISHI, SEYED BEHROOZ | — |
| 18959230 | BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS, MICROBIAL AGENT AND USE THEREOF | BERKE-SCHLESSEL, DAVID W | — |
| 18717426 | USE OF SODIUM FORMATE IN PREPARATION OF AN ANTI-INFECTIVE DRUG | CREWS, JARET JAMES | — |
| 17619922 | METHOD FOR PREPARING PT-BASED ALLOY / MOFS CATALYST WITH HIGH HYDROGENATION SELECTIVITY AND APPLICATION THEREOF | CUTLIFF, YATE KAI RENE | — |
| 18512177 | CHIRAL OR RACEMIC PYRIMIDINE-FUSED DIAZEPINONE DERIVATIVES, PREPARATION METHOD, AND APPLICATION THEREOF | LEE, CHIHYI NMN | — |
| 18280945 | METHOD AND SYSTEM FOR ANALYZING PRECIPITATION NORMALIZATION BY GRADIENT-BASED PARAMETER OPTIMIZATION | COCCHI, MICHAEL EDWARD | — |
| 18232363 | METHOD AND DEVICE FOR CONSTRUCTING AUTISM SPECTRUM DISORDER (ASD) RISK PREDICTION MODEL | NEGIN, RUSSELL SCOTT | — |
| 18325792 | BIOMARKER FOR DIAGNOSIS, TREATMENT, AND PROGNOSIS FOR HEPATOCELLULAR CARCINOMA BONE METASTASIS AND APPLICATION THEREOF | PUTTLITZ, KARL J | — |
| Art Unit | Apps |
|---|---|
| 1748 | 1 |
| 1628 | 1 |
| 1646 | 1 |
| 2828 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18999089 | METHOD, APPARATUS, DEVICE, AND MEDIUM FOR SIMULATINGPOLYURETHANE PERMEATION GROUTING DIFFUSION | GHORISHI, SEYED BEHROOZ | 1748 | §101§103§112 | Non-Final OA | — | Pending | Dec 23, 2024 |
| 18959230 | BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS, MICROBIAL AGENT AND USE THEREOF | BERKE-SCHLESSEL, DAVID W | — | §101§112 | Non-Final OA | — | Pending | Nov 25, 2024 |
| 18717426 | USE OF SODIUM FORMATE IN PREPARATION OF AN ANTI-INFECTIVE DRUG | CREWS, JARET JAMES | — | §103 | Non-Final OA | — | Pending | Jun 07, 2024 |
| 17619922 | METHOD FOR PREPARING PT-BASED ALLOY / MOFS CATALYST WITH HIGH HYDROGENATION SELECTIVITY AND APPLICATION THEREOF | CUTLIFF, YATE KAI RENE | — | §102§103§112 | Non-Final OA | — | Pending | Feb 05, 2024 |
| 18512177 | CHIRAL OR RACEMIC PYRIMIDINE-FUSED DIAZEPINONE DERIVATIVES, PREPARATION METHOD, AND APPLICATION THEREOF | LEE, CHIHYI NMN | 1628 | §102§103§112 | Non-Final OA | — | Pending | Nov 17, 2023 |
| 18280945 | METHOD AND SYSTEM FOR ANALYZING PRECIPITATION NORMALIZATION BY GRADIENT-BASED PARAMETER OPTIMIZATION | COCCHI, MICHAEL EDWARD | — | §101§112 | Non-Final OA | — | Pending | Sep 08, 2023 |
| 18232363 | METHOD AND DEVICE FOR CONSTRUCTING AUTISM SPECTRUM DISORDER (ASD) RISK PREDICTION MODEL | NEGIN, RUSSELL SCOTT | — | §101§103 | Non-Final OA | — | Pending | Aug 10, 2023 |
| 18325792 | BIOMARKER FOR DIAGNOSIS, TREATMENT, AND PROGNOSIS FOR HEPATOCELLULAR CARCINOMA BONE METASTASIS AND APPLICATION THEREOF | PUTTLITZ, KARL J | 1646 | §101§103§112 | Non-Final OA | — | Pending | May 30, 2023 |
| 18318728 | DFB LASER MANUFACTURING METHOD BASED ON DIELECTRIC LATERALLY COUPLED GRATING WITH DETERMINISTIC GRATING COUPLING COEFFICIENT | HARVEY, MINSUN OH | 2828 | §102§103 | Non-Final OA | 30d | Pending | May 17, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial